Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Boers

Showing results (31-40 of 395) with videos related to

Pageof 40
Sort By:
Annals of the Rheumatic Diseases|July 9, 2016
Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!Maarten Boers
Arthritis and Rheumatism|September 30, 2008
Pathophysiology of rheumatoid arthritis: split or lump?Maarten Boers
Journal of Clinical Epidemiology|March 30, 2010
Updated Consolidated Standards of Reporting Trials (CONSORT): it just gets betterMaarten Boers
Arthritis Care & Research|January 22, 2013
Metacarpophalangeal implant surgery: time for a randomized clinical trial? Comment on the article by Chung et alMaarten Boers
Nature Reviews. Rheumatology|May 8, 2013
Clinical guidelines: can wise choices solve the health-care crisis?Maarten Boers
The Journal of Rheumatology|November 3, 2018
Effects of Co-medication with Glucocorticoids in Biologics TrialsMaarten Boers
Annals of the Rheumatic Diseases|May 6, 2020
Public/private partnerships, at what price?Maarten Boers
Annals of the Rheumatic Diseases|April 8, 2011
RAID: a valid tool to quantify the impact of rheumatoid arthritis. But what impact will it have on the core set for trials?Maarten Boers
Lancet (London, England)|January 11, 2005
Discontinuation of VioxxMaarten Boers
Reumatologia Clinica|June 27, 2019
Glucocorticoids for rheumatoid arthritis in the era of targeted therapiesMaarten Boers
Pageof 40

Showing results (31-40 of 395) with videos related to

Sort By:
Pageof 40
Annals of the Rheumatic Diseases|July 9, 2016
Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!Maarten Boers
Arthritis and Rheumatism|September 30, 2008
Pathophysiology of rheumatoid arthritis: split or lump?Maarten Boers
Journal of Clinical Epidemiology|March 30, 2010
Updated Consolidated Standards of Reporting Trials (CONSORT): it just gets betterMaarten Boers
Arthritis Care & Research|January 22, 2013
Metacarpophalangeal implant surgery: time for a randomized clinical trial? Comment on the article by Chung et alMaarten Boers
Nature Reviews. Rheumatology|May 8, 2013
Clinical guidelines: can wise choices solve the health-care crisis?Maarten Boers
The Journal of Rheumatology|November 3, 2018
Effects of Co-medication with Glucocorticoids in Biologics TrialsMaarten Boers
Annals of the Rheumatic Diseases|May 6, 2020
Public/private partnerships, at what price?Maarten Boers
Annals of the Rheumatic Diseases|April 8, 2011
RAID: a valid tool to quantify the impact of rheumatoid arthritis. But what impact will it have on the core set for trials?Maarten Boers
Lancet (London, England)|January 11, 2005
Discontinuation of VioxxMaarten Boers
Reumatologia Clinica|June 27, 2019
Glucocorticoids for rheumatoid arthritis in the era of targeted therapiesMaarten Boers
Pageof 40